Bio-Guided Fractionation Driven by In Vitro α-Amylase Inhibition Assays of Essential Oils Bearing Specialized Metabolites with Potential Hypoglycemic Activity

Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by unpaired blood glycaemia maintenance. T2DM can be treated by inhibiting carbohydrate hydrolyzing enzymes (α-amylases and α-glucosidases) to decrease postprandial hyperglycemia. Acarbose and voglibose are inhibitors used in clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Capetti, Francesca, Cagliero, Cecilia, Marengo, Arianna, Bicchi, Carlo, Rubiolo, Patrizia, Sgorbini, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569863/
https://www.ncbi.nlm.nih.gov/pubmed/32967115
http://dx.doi.org/10.3390/plants9091242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569863/
https://www.ncbi.nlm.nih.gov/pubmed/32967115
http://dx.doi.org/10.3390/plants9091242

Ejemplares similares